The invisible suppliers behind your daily bread

Related Articles

¶Most South Africans never think about the companies that make the enzymes, emulsifiers and preservatives in their supermarket bread. Yet these suppliers form the quiet backbone of the industrial system that produces the soft, long-lasting loaves on our shelves.

Local production of calcium propionate, the main mould inhibitor, is led by Orthochem in Bethlehem. The company has been under pressure for years from cheaper imports, mainly from China. Other key players include Amesi, Abantu Baking Solutions, Synercore and Stern Ingredients. These firms supply the full range of dough improvers, enzymes such as phospholipase and fungal alpha-amylase, and emulsifiers like DATEM and SSL that give industrial bread its uniform texture and extended shelf life.

Local production of calcium propionate, the main mould inhibitor, is led by Orthochem in Bethlehem. The company has been under pressure for years from cheaper imports, mainly from China. Other key players include Amesi, Abantu Baking Solutions, Synercore and Stern Ingredients. These firms supply the full range of dough improvers, enzymes such as phospholipase and fungal alpha-amylase, and emulsifiers like DATEM and SSL that give industrial bread its uniform texture and extended shelf life.

Under South African food-labelling rules, many of these substances are classified as processing aids. If the manufacturer claims they no longer perform a technical function in the finished product, they do not have to be named on the label. This creates the same transparency gap highlighted in the first article of this series.

Pastry Chef Charl

The supply chain itself is efficient and global. Weaker local wheat is strengthened with imported enzymes and conditioners, mixed at high speed, and preserved for 10 to 14 days. The result is affordable bread that meets volume demands, but the consumer is left without the full ingredient story.

This second thread reveals the same industrial logic at work: cost efficiency, regulatory loopholes and limited transparency. The pattern is clear, even if the deeper health and sourcing questions require further independent scrutiny.

More on this topic

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Advertismentspot_img

Popular stories